vimarsana.com

Page 23 - கிங் ஜார்ஜ் மருத்துவ பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Do away with Covid-19 negative report rule, airlines urge state govts

Faced with an uphill task of keeping business solvent, the country’s airlines have approached the central and state governments to eliminate the need for Covid negative report, which is mandatory for entry into multiple states. Karnataka was the first state to remove the requirement on Sunday. Airlines want the negative RT-PCR test result to be replaced with a fit-to- fly certificate from a physician to make things easier for passengers and the aviation industry. According to multiple executives of private and government-owned Air India, such a request have been made to the Ministry of Civil Aviation and also to specific state governments. Airlines cited that getting an RT-PCR test at any of India’s leading metro cities within 72 hours have become difficult which is forcing people to cancel their travel.

COVID Crisis: Lucknow Mourns the Passing of Cardiac Care Specialist

COVID Crisis: Lucknow Mourns the Passing of Cardiac Care Specialist Dr Fazal Karim, head of the cardiology department at Era Medical College and Hospital, was known for his dedication to his patients from the city’s lower socioeconomic groups. Dr. Fazal Karim of Era Medical University, Lucknow. Photo: Twitter@Shamshe02630539 Health06/May/2021 A doctor who saved thousands of lives by providing timely and cost-effective cardiac care services to his patients even during the pandemic finally succumbed to the deadly COVID-19 infection on April 28, 2021, after battling the disease for more than 10 days. Professor (Dr) Fazal Karim, the head of the department of cardiology at Lucknow’s Era Medical College, was known for his dedication to his patients. He often even ran from the ICCU (intensive coronary care unit) to the main gate of the hospital whenever a person arrived in a critical condition so as to take charge of the patient as fast as possible.

All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases

All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases AYUSH-64 can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said. Share Updated: May 3, 2021, 08:08 PM IST AYUSH-64, a drug developed for curing malaria in 1980, can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said on Thursday. Central Council for Research in Ayurvedic Sciences (CCRAS) recently concluded clinical trials of the drug focusing on the management of asymptomatic, mild to moderate COVID-19 in collaboration with the Council of Scientific and Industrial Research (CSIR) and other research organizations and medical colleges across the country.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.